enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Lenalidomide - Wikipedia

    en.wikipedia.org/wiki/Lenalidomide

    Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]

  3. Cereblon E3 ligase modulator - Wikipedia

    en.wikipedia.org/wiki/Cereblon_E3_ligase_modulator

    The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.

  4. Celgene - Wikipedia

    en.wikipedia.org/wiki/Celgene

    Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.

  5. New prescription drug price hikes hit Black patients hard - AOL

    www.aol.com/news/prescription-drug-price-hikes...

    Other drugs, including Revlimid, used to treat multiple myeloma, rose by 7%, to a list price of more than $89,000 per month. Black people in the U.S. are more likely to be diagnosed with the ...

  6. Celgene Provides REVLIMID® Regulatory Update - AOL

    www.aol.com/2013/02/11/celgene-provides-revlimid...

    For premium support please call: 800-290-4726 more ways to reach us more ways to reach us

  7. Celgene's Revlimid Faces a Tough Sell - AOL

    www.aol.com/2013/11/18/celgenes-revlimid-faces-a...

    When it comes to drug pricing, European regulators are a tough sell. Just ask Johnson & Johnson . The U.K.'s National Institute for Health and Care Excellence, or NICE, took a pass on paying for ...

  8. Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL

  9. Will Eliquis, Revlimid Drive Bristol-Myers (BMY) Q2 Earnings?

    www.aol.com/news/eliquis-revlimid-drive-bristol...

    Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports second-quarter 2020 results.